Studies have demonstrated that miR-223 transcriptional suppression of NLRP3 could promote apoptosis in breast cancer, hepatocellular cancer, cervical cancer, and glioblastoma cells [64,65,66,67]. The gene discussed is NLRP3; the disease is hepatocellular carcinoma.